1. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti- lymphocyte globulin treatment for acute rejection 
Michael J. Dickenmann, Kairat Kabulbayev, Jürg Steiger, Gieri Cathomas, Pierre Reusser, Michael Tamm 
Clinical Microbiology and Infection 
Volume 10, Issue 4, Pages (April 2004)
DOI: /j X x
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Cumulative number of patients developing CMV infection or CMV disease within 6 months of rejection therapy (51 patients at risk).
Clinical Microbiology and Infection  , DOI: ( /j X x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions